Lonza Poietics osteoclast precursor cells and media

Tuesday, 22 March, 2011 | Supplied by: Lonza Australia Pty Ltd



Poietics osteoclast precursors yield 70% conversion to mature and functional osteoclasts when differentiated using Poietics media.

The osteoclast precursor cell medium BulletKit includes basal medium and supplements needed to induce the osteoclast precursors to differentiate into mature osteoclasts. These differentiated osteoclasts stain positive for TRAP and express the calcitonin receptor.

Osteoclasts are large, multinucleated cells that play an active role in bone resorption.

Online: www.lonza.com
Phone: 03 9550 0883
Related Products

AdipoGen Life Sciences tubulin products for neurodegeneration research

AdipoGen Life Sciences offers a broad range of microtubule research solutions. This includes...

SYnAbs monoclonal antibodies

SYnAbs produces innovative monoclonal antibodies against poor immunogenic compounds and complex...

Merck VirusExpress Lentiviral Production Platform

The platform helps to overcome lentiviral production challenges and can reduce process...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd